(Q39064968)

8 September 2017

title

Proctolin: A peptide transmitter candidate in insects (English)

1 reference

https://api.crossref.org/works/10.1016/0024-3205(75)90133-2

7 March 2022

B. E. Brown

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A575

7 March 2022

language of work or name

English

0 references

publication date

1 October 1975

1 reference

8 September 2017

15 October 1975

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=575

full work available at URL

7 March 2022

https://api.elsevier.com/content/article/PII:0024320575901332?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0024-3205(75)90133-2

https://api.elsevier.com/content/article/PII:0024320575901332?httpAccept=text/plain

7 March 2022

1 reference

https://api.crossref.org/works/10.1016/0024-3205(75)90133-2

7 March 2022

1 reference

8 September 2017

1 reference

8 September 2017

1 reference

8 September 2017

page(s)

1241-1252

1 reference

Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus

8 September 2017

cites work

1 reference

12 December 2020

Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer

1 reference

12 December 2020

Chemotherapy with preoperative radiotherapy in rectal cancer

1 reference

12 December 2020

Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer: a randomized controlled trial

1 reference

12 December 2020

Chemoradiation followed by surgery compared with chemoradiation alone in squamous cancer of the esophagus: FFCD 9102.

1 reference

12 December 2020

Adjuvant chemotherapy versus observation in patients with colorectal cancer: a randomised study.

1 reference

12 December 2020

Capecitabine and oxaliplatin for advanced esophagogastric cancer.

1 reference

12 December 2020

Bevacizumab in combination with oxaliplatin-based chemotherapy as first-line therapy in metastatic colorectal cancer: a randomized phase III study.

1 reference

12 December 2020

Sorafenib in advanced hepatocellular carcinoma

1 reference

12 December 2020

Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial

1 reference

12 December 2020

Chemoradiotherapy in the management of locally advanced pancreatic carcinoma: a qualitative systematic review

1 reference

12 December 2020

Improved overall survival with oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment in stage II or III colon cancer in the MOSAIC trial

1 reference

12 December 2020

Phase III randomized comparison of gemcitabine versus gemcitabine plus capecitabine in patients with advanced pancreatic cancer

1 reference

12 December 2020

Guidelines for colorectal cancer screening and surveillance in moderate and high risk groups (update from 2002).

1 reference

12 December 2020

Phase III trial comparing protracted intravenous fluorouracil infusion alone or with yttrium-90 resin microspheres radioembolization for liver-limited metastatic colorectal cancer refractory to standard chemotherapy

1 reference

12 December 2020

Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial

1 reference

12 December 2020

Randomized, phase III trial of panitumumab with infusional fluorouracil, leucovorin, and oxaliplatin (FOLFOX4) versus FOLFOX4 alone as first-line treatment in patients with previously untreated metastatic colorectal cancer: the PRIME study

1 reference

12 December 2020

FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer

1 reference

12 December 2020

Impact of the UK colorectal cancer screening pilot studies on incidence, stage distribution and mortality trends.

1 reference

12 December 2020

Radiofrequency ablation combined with systemic treatment versus systemic treatment alone in patients with non-resectable colorectal liver metastases: a randomized EORTC Intergroup phase II study (EORTC 40004).

1 reference

12 December 2020

An unidentified depressor substance in certain tissue extracts

Von Euler

1931

1 reference

https://api.crossref.org/works/10.1016/0024-3205(75)90133-2

Fertilization of Denuded Rabbit Eggs in vitro by Sperm recovered from the Uterus or Vagina

7 March 2022

232

Chang

1971

1 reference

https://api.crossref.org/works/10.1016/0024-3205(75)90133-2

7 March 2022

Synthesis of substance P

232

Tregear

1971

1 reference

https://api.crossref.org/works/10.1016/0024-3205(75)90133-2

Neuropharmacology of peptides

7 March 2022

252

630

Iversen

1974

1 reference

https://api.crossref.org/works/10.1016/0024-3205(75)90133-2

Identification of the motoneuron-depolarizing peptide in bovine dorsal root as hypothalamic substance P.

7 March 2022

Takahashi

1974

1 reference

https://api.crossref.org/works/10.1016/0024-3205(75)90133-2

Excitatory action of hypothalamic substance P on spinal motoneurones of newborn rats

7 March 2022

252

734

Konishi

1974

1 reference

https://api.crossref.org/works/10.1016/0024-3205(75)90133-2

The pharmacology of recurrent inhibition in the supraoptic neurosecretory system

7 March 2022

501

Nicoll

1971

1 reference

https://api.crossref.org/works/10.1016/0024-3205(75)90133-2

Neuromuscular transmitter substance in insect visceral muscle.

7 March 2022

155

595

Brown

1967

1 reference

https://api.crossref.org/works/10.1016/0024-3205(75)90133-2

Insect visceral muscle. Responses of the proctodeal muscles to mechanical stretch

7 March 2022

437

Nagai

1970

1 reference

https://api.crossref.org/works/10.1016/0024-3205(75)90133-2

Structure of the pentapeptide proctolin, a proposed neurotransmitter in insects

7 March 2022

1253

Starratt

1975

1 reference

https://api.crossref.org/works/10.1016/0024-3205(75)90133-2

Pharmacologically active constituents of the cockroach corpus cardiacum: Resolution and some characteristics

7 March 2022

387

Brown

1965

1 reference

https://api.crossref.org/works/10.1016/0024-3205(75)90133-2

7 March 2022

Pharmacological Reviews

997

Cao

1966

1 reference

https://api.crossref.org/works/10.1016/0024-3205(75)90133-2

Neuromuscular Pharmacology of Insects

7 March 2022

151

McDonald

1975

1 reference

https://api.crossref.org/works/10.1016/0024-3205(75)90133-2

ISOLATION, PARTIAL PURIFICATION AND CHARACTERIZATION OF A PEPTIDE WHICH STIMULATES THE HINDGUT OF THE COCKROACH,LEUCOPHAEA MADERAE(FABR.)

7 March 2022

142

446

Holman

1972

1 reference

https://api.crossref.org/works/10.1016/0024-3205(75)90133-2

Comparative biochemistry and physiology

7 March 2022

50C

137

Cook

1975

1 reference

https://api.crossref.org/works/10.1016/0024-3205(75)90133-2

Synthesis of 5-hydroxytryptamine in the American cockroach.

7 March 2022

Colhoun

1963

1 reference

https://api.crossref.org/works/10.1016/0024-3205(75)90133-2

The membrane components of crustacean neuromuscular systems. I. Immunity of different electrogenic components to tetrodotoxin and saxitoxin

7 March 2022

1319

Ozeki

1966

1 reference

https://api.crossref.org/works/10.1016/0024-3205(75)90133-2

Properties of the 'slow' skeletal muscles fibres of the frog

7 March 2022

121

318

Koffler

1953

1 reference

https://api.crossref.org/works/10.1016/0024-3205(75)90133-2

7 March 2022

Identifiers

1 reference

8 September 2017

1 reference